Yumin Huang

1.0k total citations
27 papers, 625 citations indexed

About

Yumin Huang is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Yumin Huang has authored 27 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Cancer Research. Recurrent topics in Yumin Huang's work include RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Ginseng Biological Effects and Applications (2 papers). Yumin Huang is often cited by papers focused on RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Ginseng Biological Effects and Applications (2 papers). Yumin Huang collaborates with scholars based in China, United States and Taiwan. Yumin Huang's co-authors include Dongying Wu, Weimin Fan, Liangliang Liu, Huajiao Qiu, Yi Liu, Aiping Xiao, Ling Sun, Defang Li, Yong Deng and Siqi Huang and has published in prestigious journals such as Blood, Scientific Reports and FEBS Letters.

In The Last Decade

Yumin Huang

24 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumin Huang China 15 360 169 66 48 48 27 625
Adriana Arita United States 15 851 2.4× 238 1.4× 93 1.4× 8 0.2× 54 1.1× 17 1.4k
Wenli Guo China 18 321 0.9× 207 1.2× 32 0.5× 16 0.3× 19 0.4× 49 953
Huaibin Zhou China 17 510 1.4× 214 1.3× 21 0.3× 16 0.3× 58 1.2× 35 811
S.‐S. Chou Taiwan 14 376 1.0× 75 0.4× 39 0.6× 25 0.5× 25 0.5× 36 1.2k
Erika P. Rendón‐Huerta Mexico 18 338 0.9× 127 0.8× 28 0.4× 12 0.3× 75 1.6× 35 773
Xin Guan China 19 486 1.4× 135 0.8× 16 0.2× 17 0.4× 68 1.4× 52 888
Yajuan Li China 13 170 0.5× 92 0.5× 22 0.3× 18 0.4× 9 0.2× 34 498
Chia-Chi Chen Taiwan 9 249 0.7× 89 0.5× 43 0.7× 11 0.2× 39 0.8× 18 457
Guangbo Fu China 22 653 1.8× 429 2.5× 28 0.4× 38 0.8× 14 0.3× 42 1.1k
Xinyan Wu China 20 412 1.1× 128 0.8× 28 0.4× 10 0.2× 22 0.5× 53 1.0k

Countries citing papers authored by Yumin Huang

Since Specialization
Citations

This map shows the geographic impact of Yumin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Huang more than expected).

Fields of papers citing papers by Yumin Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Huang. The network helps show where Yumin Huang may publish in the future.

Co-authorship network of co-authors of Yumin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Huang. A scholar is included among the top collaborators of Yumin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Huang. Yumin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jia, Yumin Huang, Yafei Wang, et al.. (2025). Siglecs: From Biomodulation to Immunotherapy. Current Protein and Peptide Science. 27(2). 163–181.
3.
Chen, Wenlin, Ming Ye, Ye Sun, Yongzhong Wei, & Yumin Huang. (2024). Analysis of clinical factors impacting recurrence in myxofibrosarcoma. Scientific Reports. 14(1). 3903–3903. 3 indexed citations
5.
Sun, Xu, et al.. (2022). The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V. Cell Death Discovery. 8(1). 48–48. 11 indexed citations
6.
Wei, Siming, et al.. (2022). Salidroside Exerts Beneficial Effect on Testicular Ischemia‐Reperfusion Injury in Rats. Oxidative Medicine and Cellular Longevity. 2022(1). 8069152–8069152. 12 indexed citations
7.
Shan, Huajian, Ce Shi, Min‐Bin Chen, et al.. (2022). Identification of Gαi3 as a promising target for osteosarcoma treatment. International Journal of Biological Sciences. 18(4). 1508–1520. 25 indexed citations
8.
Huang, Yumin, et al.. (2021). Monoamine Oxidase A Inhibits Lung Adenocarcinoma Cell Proliferation by Abrogating Aerobic Glycolysis. Frontiers in Oncology. 11. 645821–645821. 10 indexed citations
9.
Cao, Haixia, Lina Sang, Yumin Huang, et al.. (2020). Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia. Life Sciences. 243. 117255–117255. 60 indexed citations
10.
Liu, Wei, Dongdong Jiang, Fangyi Gong, et al.. (2020). miR-210-5p promotes epithelial–mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells. Cell Death and Disease. 11(2). 93–93. 48 indexed citations
11.
Luo, Yongjun, Wei Liu, Pengyu Tang, et al.. (2019). miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 488–488. 44 indexed citations
12.
Chen, Huili, Ping Ma, Yanli Chen, et al.. (2019). [Effect of Metformin on Proliferation Capacity, Apoptosis and Glycolysis in K562 Cells].. PubMed. 27(5). 1387–1394. 5 indexed citations
14.
Guo, Rong, et al.. (2018). The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Experimental Cell Research. 365(2). 185–193. 19 indexed citations
15.
Huang, Yumin, John Hale, Yaomei Wang, et al.. (2018). SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS. Journal of Hematology & Oncology. 11(1). 19–19. 31 indexed citations
16.
Hsu, Wen‐Hsin, Won‐Jing Wang, Wanyi Lin, et al.. (2018). Adducin‐1 is essential for spindle pole integrity through its interaction with TPX2. EMBO Reports. 19(8). 16 indexed citations
17.
Guo, Rong, Fang Wang, Zhong‐Xing Jiang, et al.. (2017). Retraction: IRF9 inhibits human acute myeloid leukemia through the SIRT1‐p53 signaling pathway. FEBS Letters. 591(18). 2951–2951. 1 indexed citations
18.
He, Fei, Xue Fu, Juntang Lin, et al.. (2014). High expression of heat shock protein 90 alpha and its significance in human acute leukemia cells. Gene. 542(2). 122–128. 34 indexed citations
19.
Huang, Yumin, Dongying Wu, & Weimin Fan. (2014). Protection of ginsenoside Rg1 on chondrocyte from IL-1β-induced mitochondria-activated apoptosis through PI3K/Akt signaling. Molecular and Cellular Biochemistry. 392(1-2). 249–257. 51 indexed citations
20.
Zhao, Xiaohong, et al.. (2014). EMSY promoted the growth and migration of ovarian cancer cells. Tumor Biology. 36(4). 3085–3092. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026